ShangBay Capital
Overview
ShangBay Capital is a leading venture capital firm based in the heart of innovation that brings investors access to best-in-class investments within the medical device, biotechnology, and healthcare technology sectors through venture equity participation . The firm specializes in disruptive technologies for unmet clinical needs, partnering with top teams and leveraging industry expertise and strategic connections to access high-quality deals and drive success .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Abcuro | Aug 2026 | Series D | Co-investor |
| SoundHealth | Jul 2026 | Series A | Lead |
| Nervonik | Apr 2026 | Series B | Co-investor |
| Petal Surgical | Oct 2025 | Series A | Co-investor |
| SetPoint Medical | Aug 2025 | Series C Extension | Co-investor |
For institutional investors. Book with your work email.
Key People
William Dai
Founding Managing Partner
Michael P. Wallace
Venture Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is ShangBay Capital based?
ShangBay Capital is headquartered in Palo Alto, California, United States.
When was ShangBay Capital founded?
ShangBay Capital was founded in 2015.
How many portfolio companies does ShangBay Capital have?
ShangBay Capital has 40 portfolio companies in Caplight's dataset.
What are some companies in ShangBay Capital's portfolio?
Recent investments visible on Caplight include Abcuro, SoundHealth, Nervonik, Petal Surgical, SetPoint Medical.
What was ShangBay Capital's most recent investment?
ShangBay Capital's most recent investment on Caplight was in Abcuro in 2026.
What sectors does ShangBay Capital focus on?
ShangBay Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech.
What company stages does ShangBay Capital focus on?
ShangBay Capital typically invests at the MultiStage stage.
What is ShangBay Capital's AUM?
ShangBay Capital's assets under management are estimated between $100.0M and $250.0M.